(株)ファンペップの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4881/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2021/10/15 | 日証協 | 499,800株 | -10.69% | 67,800株 | -0.15% | 701,346株 | -3.79% | 22,818株 | -34.81% |
2021/10/08 | 日証協 | 559,600株 | +4.36% | 67,900株 | -39.54% | 728,946株 | +5.1% | 35,000株 | -55.81% |
2021/10/01 | 日証協 | 536,200株 | +18.11% | 112,300株 | +289.93% | 693,546株 | +3.31% | 79,200株 | +700% |
2021/09/24 | 日証協 | 454,000株 | -3.14% | 28,800株 | -63.12% | 671,346株 | -3.45% | 9,900株 | -61.02% |
2021/09/17 | 日証協 | 468,700株 | -21.46% | 78,100株 | -5.45% | 695,346株 | -9.04% | 25,400株 | -20.19% |
2021/09/10 | 日証協 | 596,800株 | -0.7% | 82,600株 | -10.31% | 764,445株 | +1.73% | 31,826株 | -23.86% |
2021/09/03 | 日証協 | 601,000株 | +0.64% | 92,100株 | -70.7% | 751,420株 | -5.66% | 41,800株 | -65.34% |
2021/08/27 | 日証協 | 597,200株 | +16.85% | 314,300株 | +159.54% | 796,520株 | +10.12% | 120,600株 | +23.26% |
2021/08/20 | 日証協 | 511,100株 | +9.3% | 121,100株 | +580.34% | 723,320株 | +4.39% | 97,845株 | +773.54% |
2021/08/13 | 日証協 | 467,600株 | -8.31% | 17,800株 | -77.75% | 692,910株 | -6.05% | 11,201株 | -84.49% |
2021/08/06 | 日証協 | 510,000株 | +9.32% | 80,000株 | +28% | 737,509株 | +7.51% | 72,200株 | +127.04% |
2021/07/30 | 日証協 | 466,500株 | +0.09% | 62,500株 | +220.51% | 686,009株 | -1.05% | 31,801株 | +48.6% |
2021/07/21 | 日証協 | 466,100株 | +2.62% | 19,500株 | -50.49% | 693,308株 | +1.82% | 21,400株 | -26.22% |
2021/07/16 | 日証協 | 454,200株 | -2.01% | 39,389株 | -68.66% | 680,908株 | -0.54% | 29,007株 | -54.6% |
2021/07/09 | 日証協 | 463,500株 | +18.39% | 125,700株 | -19.89% | 684,600株 | +7.91% | 63,899株 | -84.43% |
2021/07/02 | 日証協 | 391,500株 | -17.41% | 156,900株 | +5.09% | 634,400株 | -11.16% | 410,298株 | +143.05% |
2021/06/25 | 日証協 | 474,000株 | +46.25% | 149,300株 | -25.31% | 714,098株 | +17.01% | 168,811株 | +82.69% |
2021/06/18 | 日証協 | 324,100株 | -6.63% | 199,900株 | +39.01% | 610,288株 | -2.15% | 92,401株 | -57.06% |
2021/06/11 | 日証協 | 347,100株 | -0.94% | 143,800株 | +14.58% | 623,687株 | -7.41% | 215,198株 | -7.6% |
※株式分割は考慮していませんのでご注意ください。
Page Top